Prelude Capital Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,700
Closed -$41.6K 1308
2024
Q3
$41.6K Buy
+10,700
New +$41.6K ﹤0.01% 1115
2023
Q4
Sell
-16,540
Closed -$51.6K 1129
2023
Q3
$51.6K Buy
+16,540
New +$51.6K ﹤0.01% 900